Peters, Maria Christina Camasmie 
; Oliveira, Isabela Fernandes de; Machado, Marcella Gabrielle Mendes; Ferreira, Daniela Colevati; Zanin, Maria Helena Ambrosio ; Bou-Chacra, Nadia Araci
Source: Materials Today Chemistry. Unidade: FCF
Subjects: HORMÔNIOS GLICOCORTICOIDES, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETERS, Maria Christina Camasmie et al. The glucocorticoid derivative with the phthalimide group cationic nanocrystal for ophthalmic application: a design space development approach. Materials Today Chemistry, v. 19, p. 1-12 art. 100396, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.mtchem.2020.100396. Acesso em: 03 nov. 2024.APA
Peters, M. C. C., Oliveira, I. F. de, Machado, M. G. M., Ferreira, D. C., Zanin, M. H. A., & Bou-Chacra, N. A. (2021). The glucocorticoid derivative with the phthalimide group cationic nanocrystal for ophthalmic application: a design space development approach. Materials Today Chemistry, 19, 1-12 art. 100396. doi:10.1016/j.mtchem.2020.100396NLM
Peters MCC, Oliveira IF de, Machado MGM, Ferreira DC, Zanin MHA, Bou-Chacra NA. The glucocorticoid derivative with the phthalimide group cationic nanocrystal for ophthalmic application: a design space development approach [Internet]. Materials Today Chemistry. 2021 ; 19 1-12 art. 100396.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.mtchem.2020.100396Vancouver
Peters MCC, Oliveira IF de, Machado MGM, Ferreira DC, Zanin MHA, Bou-Chacra NA. The glucocorticoid derivative with the phthalimide group cationic nanocrystal for ophthalmic application: a design space development approach [Internet]. Materials Today Chemistry. 2021 ; 19 1-12 art. 100396.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.mtchem.2020.100396
